about
Experience with biosimilar infliximab (CT-P13) in paediatric patients with inflammatory bowel diseasesInduction Therapy With Biosimilar Infliximab in Children With Crohn Disease.Diagnostic Approach in Biliary Strictures After Pediatric Liver Transplantation.Evaluation of the effectiveness of biofeedback therapy for functional constipation in children.PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized StudyBiosimilars in paediatric inflammatory bowel diseaseSwitching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations
P50
Q28066776-083550B2-E33E-4185-B6D2-AB147D693128Q38765158-B236F0D4-5671-4279-B833-889D2047D3F3Q38815870-273FD420-7660-457A-8CEC-F4EF043E40D3Q43355820-42311430-58CD-4E67-A041-9AB52300E030Q58089305-49E6D347-AE35-4CC0-BE16-D676279B2A00Q58707780-F0C3BFFE-6384-4B6A-9ECE-B2A903C71814Q60609835-89BF1BE6-7313-40F8-A0F1-C3CA3B84E852
P50
description
Polish researcher
@en
polski naukowiec
@pl
taighdeoir Polannach
@ga
name
Dorota Jarzębicka
@ast
Dorota Jarzębicka
@ca
Dorota Jarzębicka
@de
Dorota Jarzębicka
@en
Dorota Jarzębicka
@es
Dorota Jarzębicka
@fr
Dorota Jarzębicka
@ga
Dorota Jarzębicka
@gl
Dorota Jarzębicka
@it
Dorota Jarzębicka
@nl
type
label
Dorota Jarzębicka
@ast
Dorota Jarzębicka
@ca
Dorota Jarzębicka
@de
Dorota Jarzębicka
@en
Dorota Jarzębicka
@es
Dorota Jarzębicka
@fr
Dorota Jarzębicka
@ga
Dorota Jarzębicka
@gl
Dorota Jarzębicka
@it
Dorota Jarzębicka
@nl
altLabel
Dorota Jarzebicka
@en
prefLabel
Dorota Jarzębicka
@ast
Dorota Jarzębicka
@ca
Dorota Jarzębicka
@de
Dorota Jarzębicka
@en
Dorota Jarzębicka
@es
Dorota Jarzębicka
@fr
Dorota Jarzębicka
@ga
Dorota Jarzębicka
@gl
Dorota Jarzębicka
@it
Dorota Jarzębicka
@nl
P214
P1153
56312150900
P1412
P1559
Dorota Jarzębicka
@pl
P21
P214
P27
P31
P496
0000-0002-3977-7541
P735
P7859
viaf-315224581